Literature DB >> 4915518

Evaluation of amantadine in artificially induced A2 and B influenza.

A A Smorodintsev, D M Zlydnikov, A M Kiseleva, J A Romanov, A P Kazantsev, V I Rumovsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4915518

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  14 in total

Review 1.  Amantadine and rimantadine for influenza A in adults.

Authors:  T Jefferson; V Demicheli; C Di Pietrantonj; D Rivetti
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

2.  Clinically distinguishable syndromes caused by viruses.

Authors:  R E Haynes; P H Azimi; H G Cramblett; M D Hilty; D L Burech; K I Koranyi
Journal:  Curr Probl Pediatr       Date:  1975-04

Review 3.  Antiviral agents: action and clinical use.

Authors:  T W Chang; D R Snydman
Journal:  Drugs       Date:  1979-11       Impact factor: 9.546

4.  Chemoprophylaxis of influenza A virus infections, with single doses of zanamivir, demonstrates that zanamivir is cleared slowly from the respiratory tract.

Authors:  R J Fenton; P J Morley; I J Owens; D Gower; S Parry; L Crossman; T Wong
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

Review 5.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1971-06       Impact factor: 2.401

6.  Double-blind controlled study of central nervous system side effects of amantadine, rimantadine, and chlorpheniramine.

Authors:  V M Millet; M Dreisbach; Y J Bryson
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

7.  Amantadine for influenza A.

Authors:  A Chanin
Journal:  Can Med Assoc J       Date:  1981-06-15       Impact factor: 8.262

8.  Chemotherapy and vaccination: a possible strategy for the control of highly virulent influenza virus.

Authors:  R G Webster; Y Kawaoka; W J Bean; C W Beard; M Brugh
Journal:  J Virol       Date:  1985-07       Impact factor: 5.103

Review 9.  Clinical pharmacokinetics of amantadine hydrochloride.

Authors:  F Y Aoki; D S Sitar
Journal:  Clin Pharmacokinet       Date:  1988-01       Impact factor: 6.447

10.  Protective efficacy of low-dose amantadine in adults challenged with wild-type influenza A virus.

Authors:  S D Sears; M L Clements
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.